These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12624981)

  • 1. Does pentoxifylline find a place in the armementarium of leprologists in type II reaction?
    Chatterjee M; Jaiswal AK
    Indian J Lepr; 2002; 74(4):329-34. PubMed ID: 12624981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of pentoxifylline in the treatment of type 2 reactional episodes in leprosy.
    Nery JA; Perissé AR; Sales AM; Vieira LM; Souza RV; Sampaio EP; Sarno EN
    Indian J Lepr; 2000; 72(4):457-67. PubMed ID: 11212480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
    de Carsalade GY; Achirafi A; Flageul B
    Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentoxifylline in the treatment of erythema nodosum leprosum.
    De Carsalade GY; Achirafi A; Flageul B
    J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL).
    Sampaio EP; Moraes MO; Nery JA; Santos AR; Matos HC; Sarno EN
    Clin Exp Immunol; 1998 Feb; 111(2):300-8. PubMed ID: 9486396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentoxifylline may be useful in the treatment of type 2 leprosy reaction.
    Talhari S; Orsi AT; Talhari AC; Souza FH; Ferreira LC
    Lepr Rev; 1995 Sep; 66(3):261-3. PubMed ID: 7500827
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythema nodosum leprosum and HIV infection: A therapeutic experience.
    Sharma NL; Mahajan VK; Sharma VC; Sarin S; Sharma RC
    Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):189-93. PubMed ID: 16830640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of thalidomide in the management of erythema nodosum leprosum.
    Walker SL; Waters MF; Lockwood DN
    Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe form of type 2 reaction in patients of Hansen's disease after withdrawal of thalidomide: case reports.
    Rattan R; Shanker V; Tegta GR; Verma GK
    Indian J Lepr; 2009; 81(4):199-203. PubMed ID: 20704076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of pentoxifylline, thalidomide and prednisone in the treatment of ENL.
    Moreira AL; Kaplan G; Villahermosa LG; Fajardo TJ; Abalos RM; Cellona RV; Balagon MV; Tan EV; Walsh GP
    Int J Lepr Other Mycobact Dis; 1998 Mar; 66(1):61-5. PubMed ID: 9614845
    [No Abstract]   [Full Text] [Related]  

  • 11. Double-blind trial of the efficacy of pentoxifylline vs thalidomide for the treatment of type II reaction in leprosy.
    Sales AM; de Matos HJ; Nery JA; Duppre NC; Sampaio EP; Sarno EN
    Braz J Med Biol Res; 2007 Feb; 40(2):243-8. PubMed ID: 17273661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide.
    Feuth M; Brandsma JW; Faber WR; Bhattarai B; Feuth T; Anderson AM
    Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is pentoxifylline a viable alternative in the treatment of ENL?
    Sarno EN; Nery JA; Garcia CC; Sampaio EP
    Int J Lepr Other Mycobact Dis; 1995 Dec; 63(4):570-1. PubMed ID: 8642222
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative efficacy of thalidomide and prednisolone in the treatment of moderate to severe erythema nodosum leprosum: a randomized study.
    Kaur I; Dogra S; Narang T; De D
    Australas J Dermatol; 2009 Aug; 50(3):181-5. PubMed ID: 19659979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic recurrent ENL, steroid dependent: long-term treatment with high dose clofazimine.
    Schreuder PA; Naafs B
    Lepr Rev; 2003 Dec; 74(4):386-9. PubMed ID: 14750585
    [No Abstract]   [Full Text] [Related]  

  • 16. Methotrexate in resistant ENL.
    Kar BR; Babu R
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):480-2. PubMed ID: 15755203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thalidomide in type-2 lepra reaction--a clinical experience.
    Jadhav VH; Patki AH; Mehta JM
    Indian J Lepr; 1990; 62(3):316-20. PubMed ID: 2262716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide in lepra reaction (ENL) in lepromatous leprosy patients.
    Chandorkar AG; Burte NP; Jadhav JH; Gade RK; Bulakh PM; Tayshete SN; Kale VM
    Indian J Lepr; 1984; 56(2):264-8. PubMed ID: 6548496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum.
    Villahermosa LG; Fajardo TT; Abalos RM; Balagon MV; Tan EV; Cellona RV; Palmer JP; Wittes J; Thomas SD; Kook KA; Walsh GP; Walsh DS
    Am J Trop Med Hyg; 2005 May; 72(5):518-26. PubMed ID: 15891124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulsed corticosteroid therapy in patients with chronic recurrent ENL: a pilot study.
    Girdhar A; Chakma JK; Girdhar BK
    Indian J Lepr; 2002; 74(3):233-6. PubMed ID: 12708702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.